Mastocytosis, Aggressive Systemic
Oncology·MeSH: Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Prevalence
0.5 / 100K
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target Mastocytosis, Aggressive Systemic?
There are 1 clinical trial targeting Mastocytosis, Aggressive Systemic tracked by BioSniper.
What is the prevalence of Mastocytosis, Aggressive Systemic?
The estimated prevalence of Mastocytosis, Aggressive Systemic is approximately 0.5 per 100,000 population.
Deep-dive into Mastocytosis, Aggressive Systemic
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis